Varaico: Literature-Extracted Genetic Variants

Gene:GRN
Variant:p.R418*
Back to variants list

GRN

NM_002087.4:p.R418*

Associated Papers

The genetic landscape of frontotemporal lobar degeneration: investigation of a diagnostic cohort of 2747 probands.

Cogan G et al.

Brain : a Journal of Neurology, 2025

Targeting Granulin Haploinsufficiency in Frontotemporal Dementia: From Genetic Mechanisms to Therapeutics.

Bagyinszky E et al.

International Journal of Molecular Sciences, 2025

Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestries.

Khani M et al.

Nature Communications, 2025

Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells.

Gaweda-Walerych K et al.

Translational Neurodegeneration, 2025

Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration.

Shen T et al.

Molecular Neurodegeneration, 2025

39920674 (PubMed )
Supplement: 13024_2025_806_MOESM1_ESM.pdf

A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.

Arreola-Aldape CA et al.

Frontiers in Neuroscience, 2025

40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_filtered_variants

Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestries.

Khani M et al.

Medrxiv : the Preprint Server for Health Sciences, 2024

Frequency of C9orf72, GRN, and MAPT pathogenic variants in patients recruited at the Belgrade Memory Center.

Stefanova E et al.

Neurogenetics, 2024

Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.

Li S et al.

Biomolecules, 2023

37371567 (PubMed )
Supplement: biomolecules-13-00988-s001.zip › biomolecules-2391899-supplementary.xlsx › Sheet1

Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals.

van der Schoot V et al.

European Journal of Human Genetics : Ejhg, 2022

34697415 (PubMed )
Supplement: 41431_2021_964_MOESM3_ESM.xlsx › Table_S1

Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia.

Benussi A et al.

Jama Network Open, 2021

33404617 (PubMed )
Supplement: jamanetwopen-e2030194-s001.pdf

Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations.

Carneiro F et al.

Parkinsonism & Related Disorders, 2020

Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.

Staffaroni AM et al.

Jama Network Open, 2020

33112398 (PubMed )
Supplement: jamanetwopen-e2022847-s001.pdf

Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.

Frew J et al.

Molecular Neurodegeneration, 2020

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

Moore KM et al.

The Lancet. Neurology, 2020

31810826 (PubMed )
Supplement: NIHMS1067362-supplement-Supplement.pdf

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.

Ramos EM et al.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2020

Generation of an induced pluripotent stem cell line (UBCi001-A) from a presymptomatic individual carrying the R418X progranulin gene mutation.

Frew J et al.

Stem Cell Research, 2019

Precision medicine of frontotemporal dementia: from genotype to phenotype.

Che XQ et al.

Frontiers in Bioscience (landmark Edition), 2018

Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency.

Evers BM et al.

Cell Reports, 2017

28903038 (PubMed )
Supplement: NIHMS902297-supplement-1.pdf

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo.

Beel S et al.

Human Molecular Genetics, 2017

Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation.

Hosokawa M et al.

Scientific Reports, 2017

A network of RNA and protein interactions in Fronto Temporal Dementia.

Fontana F et al.

Frontiers in Molecular Neuroscience, 2015

Early neuropsychological characteristics of progranulin mutation carriers.

Hallam BJ et al.

Journal of the International Neuropsychological Society : Jins, 2014

Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.

Lee WC et al.

Human Molecular Genetics, 2014

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.

Jacova C et al.

Neurology, 2013

White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.

McMillan CT et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2013

TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.

Nicholson AM et al.

Journal of Neurochemistry, 2013

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.

Irwin DJ et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2013

Mechanisms of granulin deficiency: lessons from cellular and animal models.

Kleinberger G et al.

Molecular Neurobiology, 2013

TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.

Chen-Plotkin AS et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2012

Progranulin axis and recent developments in frontotemporal lobar degeneration.

Nicholson AM et al.

Alzheimer's Research & Therapy, 2012

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.

Chen-Plotkin AS et al.

Archives of Neurology, 2011

rs5848 polymorphism and serum progranulin level.

Hsiung GY et al.

Journal of the Neurological Sciences, 2011

Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β.

Gao X et al.

Protein & Cell, 2010

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.

Van Deerlin VM et al.

Nature Genetics, 2010

20154673 (PubMed )
Supplement: NIHMS172758-supplement-1.pdf

The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

Yu CE et al.

Archives of Neurology, 2010

Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.

Chen-Plotkin AS et al.

Acta Neuropathologica, 2010

Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.

Schlachetzki JC et al.

Journal of Neurology, 2009

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.

Neumann M et al.

Acta Neuropathologica, 2009

Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Geser F et al.

Archives of Neurology, 2009

Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update.

Gijselinck I et al.

Human Mutation, 2008

Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.

Chen-Plotkin AS et al.

Human Molecular Genetics, 2008

Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.

Pickering-Brown SM et al.

Brain : a Journal of Neurology, 2008

Progranulin: normal function and role in neurodegeneration.

Eriksen JL et al.

Journal of Neurochemistry, 2008

1–50 of 57 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."